Rank #1289LGND

Ligand Pharmaceuticals Incorpor

$186.32

-1.91% (Daily)

Market Cap

$3.67B

Revenue

$251.23M

Rank by MCap

#1289

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Todd C. Davis Ph.D.

Headquarters

Jupiter, FL

Employees

About Ligand Pharmaceuticals Incorpor

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal...